Described herein are compounds that are estrogen receptor modulators of Formula I:
and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
本文描述的是一些具有公式I的
雌激素受体调节剂,以及其立体异构体、互变异构体或药学上可接受的盐,以及所述的取代基和结构特征。还描述了包括上述化合物的药物组合物和药物,以及使用这些
雌激素受体调节剂的方法,单独或与其他化合物结合,用于治疗介导或依赖于
雌激素受体的疾病或症状。